Landscapes / Targets

SGLT2

14 drugs act on SGLT2, in 29 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs14

DrugHow it worksCompanyStageNext dateDetails
—
Approved in other 31 Dec 2026Phase 4 trial completes
Sodium-Glucose cotransporter 2 inhibitor
Approved 31 Dec 2026Phase 3 trial completes
Sodium-Glucose cotransporter 2 inhibitor
Approved Jan 2027Phase 3 trial completes
Sodium-Glucose cotransporter 2 inhibitor
AstraZeneca · Public AZN
Approved 18 Feb 2027Phase 3 trial completes
—
Approved in other Nov 2027Phase 3 trial completes
Sodium-glucose co-transporter inhibitor
Huadong Medicine · Public 000963.SZ
Approved in China 31 Dec 2027Phase 4 trial completes
—
On the market —
Ertugliflozinnot checked
Sodium-glucose co-transporter inhibitor
On the market —
—
AstraZeneca · Public AZN
Phase 3 10 Dec 2026soonPhase 2 trial completes
—
AstraZeneca · Public AZN
Phase 3 18 Feb 2027Phase 3 trial completes
—
AstraZeneca · Public AZN
Phase 3 16 Apr 2027Phase 3 trial completes
—
Phase 3 —
Sodium-glucose co-transporter inhibitor
Phase 2 Oct 2027Phase 2 trial completes
—
Phase 1 —

About this list

Checked
12 of 14 drugs. The other 2 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SGLT2

Following is part of Solo: you see every change to SGLT2 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in